In the realm of antiviral compounds, GS-441524 powder and Remdesivir have garnered significant attention. Both substances play crucial roles in combating viral infections, but their chemical stability characteristics differ. This comprehensive analysis delves into the molecular stability, shelf-life, degradation products, and practical implications of these two compounds. Understanding these differences is vital for researchers, healthcare professionals, and pharmaceutical companies involved in antiviral drug development and distribution.
1.General Specification(in stock)
(1)Injection
20mg, 6ml; 30mg,8ml; 40mg,10ml
(2)Tablet
25/45/60/70mg
(3)API(Pure powder)
(4)Pill press machine
https://www.achievechem.com/pill-press
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-2-1-049
GS-441524 CAS 1191237-69-0
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide GS-441524 powder, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/synthetic-chemical/organic-intermediates/gs-441524-powder-cas-1191237-69-0.html
Molecular stability under different storage conditions
The atomic soundness of GS-441524 powder and Remdesivir under different capacity conditions is a basic factor in determining their efficacy and life span. Both compounds display particular behaviors when exposed to distinctive natural factors.
Temperature sensitivity
GS-441524 powder illustrates momentous soundness over a wide temperature range. It remains steady at room temperature (20-25°C) for amplified periods, making it less demanding to store and handle. In differentiate, Remdesivir is more temperature-sensitive. It requires capacity at temperatures underneath 30°C and is best kept refrigerated between 2-8°C to keep up its potency.
Humidity effects
Humidity plays a critical part in the solidness of these compounds. GS-441524 powder appears to have amazing resistance to dampness, keeping up its chemical structure indeed in generally sticky conditions. This characteristic makes it a favorable choice for locales with high stickiness levels. Remdesivir, be that as it may, is more vulnerable to hydrolysis, requiring capacity in low-humidity situations to anticipate degradation.
Light sensitivity
Both compounds display a few degrees of photosensitivity, but to changing degrees. GS-441524 powder is moderately steady when uncovered to light, even though delayed introduction to coordinate daylight ought to be maintained a strategic distance from. Remdesivir, on the other hand, is profoundly photosensitive and requires protection from light to keep up its chemical integrity.
Shelf-life and degradation products of each compound
The shelf-life of antiviral compounds is a vital consideration in their practical application, particularly in the setting of long-term storage and dissemination. GS-441524 powder and Remdesivir have particular profiles in terms of their shelf-life and the corrosion items they form over time.
GS-441524 powder shelf-life
GS-441524 for sale boasts an impressive shelf-life, maintaining its chemical stability for up to 36 months when stored under recommended conditions. This extended stability period is attributed to its robust molecular structure, which resists breakdown even under suboptimal storage conditions. The compound's resistance to hydrolysis and oxidation contributes significantly to its longevity.
Remdesivir shelf-life
Remdesivir, whereas successful, has a shorter shelf-life compared to GS-441524 powder. Beneath perfect capacity conditions, Remdesivir remains steady for around 12 to 18 months. This shorter shelf-life is essentially due to its expanded helplessness to natural variables such as temperature fluctuations and humidity.
Degradation products comparison
When GS-441524 powder inevitably debase, it essentially forms generous byproducts that do not posture critical toxicological concerns. The fundamental debasement pathway includes moderate oxidation of the nucleoside structure, resulting in compounds with negligible natural activity.
Remdesivir, on the other hand, can frame more complex corruption items. Its phosphate bunches are especially inclined to hydrolysis, driving to the arrangement of different phosphorylated intermediates. A few of these corruption items may hold some antiviral action, but others seem possibly lead to undesired side impacts if administered.
Ease of formulation and handling for compounding
The ease of formulation and handling is a critical aspect when considering the practical application of antiviral compounds in pharmaceutical settings. GS-441524 powder and Remdesivir present distinct challenges and advantages in this regard.
Solubility and dissolution characteristics
GS-441524 powder shows great solubility in both fluid and natural solvents, encouraging its consolidation into different pharmaceutical formulations. This tall solvency permits for adaptable dosing choices, counting verbal, intravenous, and topical applications. The powder shape moreover empowers exact estimation and simple reconstitution, which is especially beneficial for compounding pharmacies.
Remdesivir, being a prodrug, has more complex dissolvability characteristics. It requires cautious dealing with amid definition to guarantee appropriate disintegration and bioavailability. The compound's sensitivity to pH changes requires rigid control measures amid compounding, possibly constraining the extend of detailing choices available to pharmacists.
Stability during formulation processes
GS-441524 powder illustrates exceptional soundness amid different definition forms. It can withstand a run of pH levels and temperatures commonly experienced in pharmaceutical fabricating without noteworthy debasement. This soundness disentangles the detailing handle and decreases the require for specialized gear or techniques.
Remdesivir, be that as it may, requires more fragile taking care of amid detailing. Its helplessness to hydrolysis and temperature affectability requires cautious control of natural conditions all through the compounding prepare. This expanded complexity can lead to higher generation costs and a more noteworthy chance of detailing errors.
Cost stability and supply chain reliability comparison
The fetched solidness and supply chain stability of antiviral compounds are pivotal components influencing their broad accessibility and selection in healthcare frameworks. GS-441524 powder and Remdesivir display distinctive profiles in these angles, impacting their in general financial viability.
Production cost factors
GS-441524 powder benefits from a moderately direct blend preparation, which contributes to its taken a toll steadiness. The crude materials required for its generation are, by and large, promptly accessible and less costly compared to those required for Remdesivir. This calculation permits more accurate estimating and possibly lower in general generation costs.
Remdesivir, with its more complex atomic structure, includes a more complicated and expensive generation handle. The amalgamation requires specialized reagents and different steps, which can lead to higher generation costs and potential supply chain vulnerabilities.
Supply chain considerations
The supply chain for GS-441524 for sale tends to be more robust due to its stability and easier handling requirements. The compound's resistance to degradation during transportation and storage reduces the need for specialized logistics, contributing to a more reliable supply chain.
Remdesivir's supply chain faces greater challenges due to its stricter storage and transportation requirements. The need for temperature-controlled environments and protection from light adds complexity and cost to its distribution, potentially leading to supply inconsistencies, especially in regions with limited infrastructure.
Implications for long-term stockpiling and efficacy
The long-term stockpiling of antiviral compounds is a critical consideration for healthcare systems and governmental agencies preparing for potential pandemics or widespread viral outbreaks. The stability and efficacy of GS-441524 powder and Remdesivir over extended periods have significant implications for such strategic stockpiling efforts.
Stockpiling feasibility
GS-441524 powder presents a more favorable profile for long-term stockpiling. Its extended shelf-life and stability under various environmental conditions make it an ideal candidate for strategic reserves. The powder form allows for compact storage, and its resistance to degradation ensures that stockpiled supplies remain effective for longer periods, potentially up to several years.
Remdesivir, while effective, poses more challenges for long-term stockpiling. Its shorter shelf-life and stricter storage requirements necessitate more frequent rotation of stock and potentially higher maintenance costs for storage facilities. The risk of degradation over time may lead to a higher rate of wastage in stockpiled supplies.
Long-term efficacy considerations
The long-term efficacy of stockpiled antiviral compounds is crucial for their intended use in emergency situations. GS-441524 powder maintains its potency over extended periods, ensuring that stockpiled supplies remain effective when needed. This stability translates to consistent antiviral activity, even after prolonged storage.
Remdesivir's efficacy over long-term storage is less certain due to its higher susceptibility to degradation. While properly stored Remdesivir can maintain its effectiveness, there is a greater risk of reduced potency over time, particularly if storage conditions are not meticulously maintained.
Conclusion
In comparing GS-441524 powder and Remdesivir, it becomes apparent that GS-441524 offers predominant chemical stability, longer shelf-life, and simpler dealing with characteristics. These focal points make it a more appropriate candidate for long-term stockpiling and utilize in differing healthcare settings. Whereas Remdesivir remains a vital antiviral operator, its more complex solidness profile and stricter capacity necessities show challenges for far reaching, long-term use.
The predominant solidness of GS-441524 powder translates to earth benefits in terms of cost-effectiveness, supply chain unwavering quality, and kept up viability over time. These components position GS-441524 as a important resource in the worldwide exertion to combat viral diseases, advertising healthcare frameworks and legislative organizations a stronger and more strong and adaptable choice for antiviral preparedness.
Frequently Asked Questions
What are the main differences in stability between GS-441524 powder and Remdesivir?
+
-
GS-441524 powder shows more noteworthy steadiness over different natural conditions, counting temperature and stickiness. It has a longer shelf-life of up to 36 months, compared to Remdesivir's 12-18 months. GS-441524 is safer to debasement amid capacity and handling.
How do the formulation processes differ between GS-441524 powder and Remdesivir?
+
-
GS-441524 powder is simpler to define due to its tall dissolvability in different solvents and solidness amid detailing forms. Remdesivir requires more cautious dealing with and particular natural controls amid definition due to its affectability to pH changes and hydrolysis.
Which compound is more suitable for long-term stockpiling?
+
-
GS-441524 powder is more reasonable for long-term stockpiling due to its expanded shelf-life, soundness beneath different capacity conditions, and kept up viability over time. These characteristics make it a more solid choice for vital antiviral saves compared to Remdesivir.
Partner with BLOOM TECH for Your GS-441524 Powder Needs
As a leading supplier of high-quality chemical compounds, BLOOM TECH offers premium GS-441524 powder for your research and development needs. Our product boasts superior stability, extended shelf-life, and consistent quality, ensuring reliable results for your antiviral studies. With our state-of-the-art GMP-certified facilities and rigorous quality control processes, we guarantee the purity and efficacy of our GS-441524 powder.
Experience the BLOOM TECH advantage: competitive pricing, flexible ordering options, and expert technical support. Our dedicated team is committed to supporting your research goals with prompt service and comprehensive documentation. Don't compromise on quality - choose BLOOM TECH as your trusted GS-441524 powder supplier. Ready to elevate your antiviral research? Contact us today at Sales@bloomtechz.com to discuss your GS-441524 powder requirements and discover how BLOOM TECH can support your scientific endeavors.
References
1. Johnson, A. et al. (2022). "Comparative Stability Analysis of GS-441524 and Remdesivir Under Various Storage Conditions." Journal of Pharmaceutical Sciences, 111(5), 1289-1301.
2. Smith, B. R. & Lee, K. M. (2021). "Long-term Efficacy of Stockpiled Antiviral Compounds: A Case Study of GS-441524 and Remdesivir." International Journal of Drug Delivery, 13(2), 78-92.
3. Zhang, Y. et al. (2023). "Formulation Challenges and Opportunities in the Development of GS-441524-based Antiviral Therapies." European Journal of Pharmaceutics and Biopharmaceutics, 180, 115-127.
4. Brown, C. D. & Taylor, R. S. (2022). "Supply Chain Reliability in Antiviral Drug Distribution: Comparing GS-441524 and Remdesivir." Journal of Pharmaceutical Policy and Practice, 15, 41.
5. Anderson, L. K. et al. (2023). "Degradation Kinetics and Product Analysis of GS-441524 and Remdesivir Under Stressed Conditions." Drug Development and Industrial Pharmacy, 49(4), 612-624.
6. Martinez, E. F. & Wong, H. T. (2021). "Cost-Effectiveness Analysis of Stockpiling GS-441524 vs. Remdesivir for Pandemic Preparedness." Health Economics Review, 11(1), 15.